Chinese startups Yunyou Freight and Accutar Biotechnology have secured fresh funding.
Tencent co-leads funding in Yunyou Freight
Beijing-headquartered smart logistics services provider Yunyou Freight on Thursday announced that it has received “tens of millions of US dollars” in its Series B round of financing.
The fresh round was jointly led by return investors Tencent and Eastern Bell Capital, per a company statement. BlueRun Ventures also re-upped in the latest transaction, the investor said in a WeChat post.
Yunyou will use the proceeds for business development and market expansion.
Led by Peking University alumni Jilong Zhou, Yunyou is a B2B platform that promotes digital logistics operation and management. It claims to have served nearly 1,000 companies.
YF Capital backs Accutar Biotech
Accutar Biotechnology Inc, a startup that aims to accelerate drug discovery, has raised “tens of millions of US dollars” in a new funding round.
Alibaba Jack MA’s YF Capital, 3W Healthcare Fund and Coatue joined the round, according to a company statement.
Accutar has a pipeline of over 10 drug candidates targeted at breast and prostatic cancers. The candidates are expected to enter clinical trials in the US in the second half of 2021.
IDG Capital is the largest investor in Accutar, the firm said. Before the latest round, IDG along with CDH Investments, Primavera Capital and YITU Tech had invested a similar sum in Accutar’s Series B round. Prior to that, IDG and YITU had put in $15 million in its Series A round.